Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,702 | 19,157 | 15,120 | 15,428 | 17,703 |
| Receivables | 120,798 | 122,079 | 123,068 | 115,103 | 106,741 |
| Inventories | 54,496 | 59,402 | 71,702 | 60,445 | 45,443 |
| Other current assets | 6,935 | 10,516 | 5,093 | 5,061 | 5,109 |
| TOTAL | $214,665 | $221,330 | $223,136 | $211,702 | $189,055 |
| Non-Current Assets | |||||
| PPE Net | 99,447 | 97,063 | 99,626 | 105,028 | 110,952 |
| Intangibles | 112,907 | 105,848 | 106,371 | 106,928 | 107,584 |
| Other Non-Current Assets | 156,991 | 160,889 | 157,262 | 154,696 | 173,262 |
| TOTAL | $369,345 | $363,800 | $363,259 | $366,652 | $391,798 |
| Total Assets | $584,010 | $585,130 | $586,395 | $578,354 | $580,853 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 37,275 | 34,549 | 33,506 | 45,847 | 29,726 |
| Accrued Expenses | 26,525 | 22,901 | 18,791 | 23,431 | 20,833 |
| Other current liabilities | 16,680 | 8,157 | 7,651 | 8,360 | 7,683 |
| TOTAL | $106,015 | $102,445 | $88,097 | $103,135 | $90,782 |
| Non-Current Liabilities | |||||
| Long Term Debt | 110,255 | 126,111 | 163,134 | 172,386 | 188,636 |
| Deferred Revenues | 5,552 | 9,332 | 4,755 | 5,942 | 7,765 |
| Other Non-Current Liabilities | 86,815 | 94,437 | 92,310 | 90,797 | 115,606 |
| TOTAL | $205,787 | $230,367 | $268,491 | $286,265 | $329,070 |
| Total Liabilities | $311,802 | $332,812 | $356,588 | $389,400 | $419,852 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,050 | 46,827 | 46,857 | 46,634 | 46,277 |
| Common Shares | 470 | 470 | 469 | 1,194 | 1,188 |
| Retained earnings | 172,662 | 144,862 | 120,756 | 85,949 | 68,349 |
| Other shareholders' equity | 831 | 439 | -429 | 557 | -5,656 |
| TOTAL | $272,208 | $252,318 | $229,807 | $188,954 | $161,001 |
| Total Liabilities And Equity | $584,010 | $585,130 | $586,395 | $578,354 | $580,853 |